https://www.selleckchem.com/pr....oducts/pf-4708671.ht
65, 95% CI 0.58-0.72) and a 19% reduced risk of mortality for the colon cancer measure 12RLN (HR 0.81, 95% CI 0.77-0.85). For the lung cancer measure LNoSurg, increasing compliance was paradoxically associated with an increased risk of mortality (HR 1.14, 95% CI 1.08-1.2. For the remaining measures, hospital-level compliance demonstrated no consistent association with patient survival. Hospital-level compliance with the CoC's Quality of Care Measures is not uniformly aligned with patient survival. In their current form, these measu
Like
Comment
Share
